The pharmaceutical sector in the EU faces unprecedented supply chain vulnerabilities rooted in supply concentration, particularly for off-patent medicines, as on recent report (open pdf) has found:
Over 40% of off-patent active pharmaceutical ingredients (APIs) globally are sourced from China – with nearly all API producers relying on Asia-based manufacturers for intermediate inputs.
Let's hope that the EU's Critical Medicines Act is going to change the situation.
14
'We are the nation’s punching bag’: Shortages, abuse, and burnout in German pharmacies | Euractiv | Spyke
3 replies
That is not only a problem with pharmacies but a problem of the whole society. If we let Nazis conquer the public space, this is what happens.
The thing is: it's already too late to prevent this. The pro-democracy public has to fight back and reconquer the public space.
The pharmaceutical sector in the EU faces unprecedented supply chain vulnerabilities rooted in supply concentration, particularly for off-patent medicines, as on recent report (open pdf) has found:
Let's hope that the EU's Critical Medicines Act is going to change the situation.